Literature DB >> 25643915

Renal sympathetic nerves - what have they got to do with cardiovascular disease?

Carolyn J Barrett1.   

Abstract

NEW
FINDINGS: What is the topic of this review? This review examines the role played by renal sympathetic nerves in the regulation of cardiovascular function, focusing on changes that occur during the development of hypertension and heart failure. What advances does it highlight? While elevated levels of renal sympathetic activity are a feature of many cardiovascular diseases, the relationship is not straightforward, especially in the case of hypertension. This review highlights that before consideration of targeting the renal nerves in the clinical management of cardiovascular diseases it is essential that their role in the development of the disease is established. In recent years, with the development of new clinical techniques to target the renal nerves specifically, we have seen a renewed interest in the role of the renal sympathetic nerves in the development of cardiovascular diseases. In understanding the potential of renal nerve ablation for the treatment of cardiovascular disease, first the role played by these nerves in cardiovascular regulation must be determined. Elevated renal sympathetic activity not only has the potential to increase fluid retention but may also act in a feedforward manner to increase sympathetic activation further, increasing the workload of the heart and the potential for arrhythmias. Direct recordings of renal sympathetic nerve activity in animal models of hypertension and renal noradrenaline spillover levels in individual patients with hypertension have illustrated that hypertension is not always accompanied by an increase in renal sympathetic activity. Elevated renal sympathetic nerve activity is a feature of severe heart failure, but whether removal of the renal nerves then compromises the ability to maintain cardiac function when faced with a stressor such as sepsis remains unclear. Understanding when increased renal sympathetic drive is contributing to the progression of cardiovascular diseases such as hypertension and heart failure would appear to be the key to understanding when renal nerve ablation is likely to be of benefit.
© 2015 The Authors. Experimental Physiology © 2015 The Physiological Society.

Entities:  

Mesh:

Year:  2015        PMID: 25643915     DOI: 10.1113/expphysiol.2014.080176

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  6 in total

Review 1.  Update on Renal Sympathetic Denervation for the Treatment of Hypertension.

Authors:  Arundati Rao; Namrata Krishnan
Journal:  Curr Cardiol Rep       Date:  2022-07-27       Impact factor: 3.955

2.  Neuro-tracing approach to study kidney innervation: a technical note.

Authors:  Sanghee Lee; Anna P Malykhina
Journal:  Kidney Res Clin Pract       Date:  2017-03-31

3.  Differences in sympathetic nervous system activity and NMDA receptor levels within the hypothalamic paraventricular nucleus in rats with differential ejaculatory behavior.

Authors:  Jia-Dong Xia; Jie Chen; Bai-Bing Yang; Hai-Jian Sun; Guo-Qing Zhu; Yu-Tian Dai; Jie Yang; Zeng-Jun Wang
Journal:  Asian J Androl       Date:  2018 Jul-Aug       Impact factor: 3.285

4.  Acute changes in histopathology and intravascular imaging after catheter-based renal denervation in a porcine model.

Authors:  Atsushi Sakaoka; Akiyuki Takami; Yuji Onimura; Hitomi Hagiwara; Hisako Terao; Fumiaki Kumagai; Kiyoshi Matsumura
Journal:  Catheter Cardiovasc Interv       Date:  2017-06-22       Impact factor: 2.692

Review 5.  The implication of protein malnutrition on cardiovascular control systems in rats.

Authors:  Fernanda C Silva; Rodrigo C de Menezes; Deoclécio A Chianca
Journal:  Front Physiol       Date:  2015-09-02       Impact factor: 4.566

Review 6.  Endovascular Baroreflex Amplification for Resistant Hypertension.

Authors:  Monique E A M van Kleef; Mark C Bates; Wilko Spiering
Journal:  Curr Hypertens Rep       Date:  2018-05-09       Impact factor: 5.369

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.